Yusaku Hori Selected Research

asparagine synthetase (glutamine-hydrolyzing)

7/2022

Different types of reactions to E7386 among colorectal cancer patient-derived organoids and corresponding CAFs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yusaku Hori Research Topics

Disease

9	Neoplasms (Cancer) 12/2022 - 09/2008
1	Body Weight (Weight, Body) 07/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Polyps 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Neoplasm Metastasis (Metastasis) 12/2017
1	Vascular Tissue Neoplasms 12/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2016
1	Carcinogenesis 03/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2009
1	Papilloma (Papillomatosis) 03/2009

Drug/Important Bio-Agent (IBA)

2	CateninsIBA 07/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2016
2	lenvatinibIBA 01/2019 - 12/2018
2	Liposomes (Liposome)IBA 12/2017 - 01/2016
1	PhosphoenolpyruvateIBA 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	Amino Acids FDA Link 07/2022
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 07/2022
1	Carrier Proteins (Binding Protein)IBA 07/2022
1	asparagine synthetase (glutamine-hydrolyzing)IBA 07/2022
1	phosphoserine aminotransferase (phosphoserine transaminase)IBA 07/2022
1	Glucose (Dextrose)FDA LinkGeneric 07/2022
1	VLDL LipoproteinsIBA 07/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CREB-Binding ProteinIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 12/2018
1	Angiogenesis InhibitorsIBA 12/2018
1	NivolumabIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Therapeutic UsesIBA 01/2016
1	liposomal doxorubicin (Doxil)FDA Link 01/2016
1	Triglycerides (Triacylglycerol)IBA 03/2009
1	DiglyceridesIBA 03/2009
1	anthraceneIBA 03/2009
1	Urethane (Ethyl Carbamate)IBA 09/2008

Therapy/Procedure

2	Therapeutics 01/2019 - 12/2018
1	Aftercare (After-Treatment) 12/2022
1	Immunotherapy 01/2019